Markets.com Logo

VIH1

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    7.5123$
  • Previous Close
    7.5123$
  • 52 Week Change
    5.93$
  • Day Range
    0.00$
  • 52 Week High/Low
    6.881$ - 12.8074$
  • Dividend Per Share
    0.0057
  • Market cap
    1 243 M$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

VIH1.BE is the stock symbol for Vastned Retail Belgium, a European real estate company specializing in high-quality retail property in prime city center locations. It is listed on the Euronext Brussels stock exchange.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

General Market Conditions: Overall market sentiment, economic trends, and investor confidence influence VIH1.BE like most stocks.

Company Performance: Revenue growth, profitability, debt levels, and product pipeline developments directly impact investor perception.

Industry Trends: Developments within the pharmaceutical or biotechnology sectors, especially regarding HIV treatments, affect VIH1.BE.

Regulatory Approvals: Positive or negative news regarding drug approvals or regulatory hurdles significantly impact the stock price.

Clinical Trial Results: Success or failure of clinical trials for VIH1.BE's drug candidates heavily influences investor sentiment.

Competition: Actions and products from competitors in the HIV treatment market affect VIH1.BE's market share and perceived value.

Investor Sentiment: News articles, analyst ratings, and social media buzz can influence investor behavior and trading volume.

Economic Factors: Inflation rates, interest rates, and currency exchange rates can indirectly affect VIH1.BE's profitability and attractiveness.

Mergers and Acquisitions: Rumors or announcements of mergers, acquisitions, or partnerships involving VIH1.BE can cause price fluctuations.

Key Personnel Changes: Changes in leadership or the departure of key scientists can create uncertainty and impact stock performance.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--